Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Sacharczuk, , Aniela,
DOB: 02-NOV-1970 (Age: 55)
Gender: female
Address:
plac Szpitalna 13
27-600 Sandomierz (Poland)
ID: 3843-787162-7 (ECI)
Report
Date: 17-OCT-2017
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Ośrodek Zdrowia
Józefa Piłsudskiego 17
39-432 Gorzyce (Poland)
Specimen
Collected: 17-OCT-2017

Chemistry

Test 17-OCT-2017 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.1 H 4.8 - 5.7 %
Glucose [Mass/volume] in Blood 79.8 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 16.6 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 1.2 H 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 8.6 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 142.3 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.4 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 105.9 98 - 114 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 25.0 22 - 29 mmol/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mildly elevated HbA1c, indicating impaired glucose regulation or possible prediabetes, and a slightly increased creatinine, which may suggest early renal impairment. All other parameters are within normal limits. Recommend clinical correlation for diabetes risk and assessment of renal function, with follow-up as appropriate.